Characterization of clinical isolates of Mycobacterium tuberculosis resistant to drugs and detection of RpoB mutation in multidrug-resistant tuberculosis in the Philippines

International Journal of Tuberculosis and Lung Disease

Volumn 7, Issue 11, 2003, Pages 1104-1108

  Agdamag, Dorothy May D ^a   Kageyama, S ^b   Solante, R ^a   Espantaleon, A S ^a   Sangco, J C E ^a   Suzuki, Y ^b  

^a San Lazaro Hospital   (Philippines)

^b Proj for Prev/Control of STD/AIDS   (Philippines)

Author keywords

M. tuberculosis; MDR TB; Rifampicin resistance; RpoB gene

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIUM ISOLATE; CODON; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROBABILITY; RPOB GENE; TUBERCULOSIS;

CODON; DNA-DIRECTED RNA POLYMERASES; ETHAMBUTOL; HUMANS; ISONIAZID; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; PHILIPPINES; RETROSPECTIVE STUDIES; RIFAMPIN; SEROEPIDEMIOLOGIC STUDIES;

EID: 0242499474     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Dye C, Espinal M A, Watt C J, Mbiaga C, Williams B G. Worldwide incidence of multidrug-resistant tuberculosis. J Infect Dis 2002; 185: 1197-1202.
2. Espinal M A, Laszlo A, Simonsen L, et al. Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 2001; 344: 1294-1303.
3. Goble M, Iseman M D, Madsen L A, Waite D, Ackerson L, Horsburgh C R Jr. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med 1993; 328: 527-532.
4. Vareldzis B P, Grosset J, de Kantor I, et al. Drug-resistant tuberculosis: laboratory issues. World Health Organization recommendations. Tubercle Lung Dis 1994; 75: 1-7.
5. Heymann S J, Brewer T F, Wilson M E, Fineberg H V. The need for global action against multidrug-resistant tuberculosis. JAMA 1999; 281: 2138-2140.
6. Pozzi G, Meloni M, Iona E, et al. rpoB mutations in multidrug-resistant strains of Mycobacterium tuberculosis isolated in Italy. J Clin Microbiol 1999; 37: 1197-1199.
7. Khan M Y, Kinsara A J, Osoba A O, Wali S, Samman Y, Memish Z. Increasing resistance of M. tuberculosis to anti-TB drugs in Saudi Arabia. Int J Antimicrob Agents 2001; 17: 415-418.
8. Grimaldo E R, Tupasi T E, Rivera A B, et al. Increased resistance to ciprofloxacin and ofloxacin in multidrug-resistant Mycobacterium tuberculosis isolates from patients seen at a tertiary hospital in the Philippines. Int J Tuberc Lung Dis 2001; 5: 546-550.
9. Putong N M, Pitisuttithum P, Supanaranond W, et al. Mycobacterium tuberculosis infection among HIV/AIDS patients in Thailand: clinical manifestations and outcomes. Southeast Asian J Trop Med Public Health 2002; 33: 346-351.
10. Bass J B Jr, Farer L S, Hopewell P C, et al. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and Centers for Disease Control and Prevention. Am J Respir Crit Care Med 1994; 149: 1359-1374.
11. Kochi A, Vareldzis B, Styblo K. Multidrug-resistant tuberculosis and its control. Res Microbiol 1993; 144: 104-110.
12. Kapur V, Li L L, Iordanescu S, et al. Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J Clin Microbiol 1994; 32: 1095-1098.
13. Miller L P, Crawford J T, Shinnick T M. The rpoB gene of Mycobacterium tuberculosis. Antimicrob Agents Chemother 1994; 38: 805-811.
14. Musser J M. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin Microbiol Rev 1995; 8: 496-514.
15. Telenti A, Imboden P, Marchesi F, et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 1993; 341: 647-650.
16. Williams D L, Waguespack C, Eisenach K, et al. Characterization of rifampin-resistance in pathogenic mycobacteria. Antimicrob Agents Chemother 1994; 38: 2380-2386.
17. Blanchard J S. Molecular mechanisms of drug resistance in Mycobacterium tuberculosis. Annu Rev Biochem 1996; 65: 215-239.
18. Garcia L, Alonso-Sanz M, Rebollo M J, Tercero J C, Chaves F. Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis isolates in Spain and their rapid detection by PCR-enzyme-linked immunosorbent assay. J Clin Microbiol 2001; 39: 1813-1818.
19. Ohno H, Koga H, Kuroita T, et al. Rapid prediction of rifampin susceptibility of Mycobacterium tuberculosis. Am J Respir Crit Care Med 1997; 155: 2057-2063.
20. Felmlee T A, Liu Q, Whelen A C, Williams D, Sommer S S, Persing D H. Genotypic detection of Mycobacterium tuberculosis rifampin resistance: comparison of single-strand conformation polymorphism and dideoxy fingerprinting. J Clin Microbiol 1995; 33: 1617-1623.
21. Gamboa F, Cardona P J, Manterola J M, et al. Evaluation of a commercial probe assay for detection of rifampin resistance in Mycobacterium tuberculosis directly from respiratory and nonrespiratory clinical samples. Eur J Clin Microbiol Infect Dis 1998; 17: 189-192.
22. Scarpellini P, Braglia S, Carrera P, et al. Detection of rifampin resistance in Mycobacterium tuberculosis by double gradient-denaturing gradient gel electrophoresis. Antimicrob Agents Chemother 1999; 43: 2550-2554.
23. Torres M J, Criado A, Palomares J C, Aznar J. Use of real-time PCR and fluorimetry for rapid detection of rifampin and isoniazid resistance-associated mutations in Mycobacterium tuberculosis. J Clin Microbiol 2000; 38: 3194-3199.
24. Kim B J, Lee S H, Lyu M A, et al. Identification of mycobacterial species by comparative sequence analysis of the RNA polymerase gene (rpoB). J Clin Microbiol 1999; 37: 1714-1720.
25. Matsiota-Bernard P, Vrioni G, Marinis E. Characterization of rpoB mutations in rifampin-resistant clinical Mycobacterium tuberculosis isolates from Greece. J Clin Microbiol 1998; 36: 20-23.
26. Almeida da Silva P E, Osorio M, Reinhardt M C, de Souza Fonseca L, Dellagostin O A. Drug resistance of strains of Mycobacterium tuberculosis isolated in Brazil. Microbes Infect 2001; 3: 1111-1113.
27. Alrajhi A A, Abdulwahab S, Almodovar E, Al-Abdely H M. Risk factors for drug-resistant Mycobacterium tuberculosis in Saudi Arabia. Saudi Med J 2002; 23: 305-310.
28. Balci I, Dikensoy O, Bayram A, Filiz A. Drug-resistant tuberculosis at the University Hospital in Gaziantep, South-eastern Turkey. J Int Med Res 2000; 28: 300-306.
29. Lee J H, Chang J H. Drug-resistant tuberculosis in a tertiary referral teaching hospital of Korea. Korean J Intern Med 2001; 16: 173-179.
30. Rattan A, Kalia A, Ahmad N. Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives. Emerg Infect Dis 1998; 4: 195-209.
31. Suzuki Y, Katsukawa C, Inoue K, et al. Mutations in rpoB gene of rifampicin resistant clinical isolates of Mycobacterium tuberculosis in Japan. Kansenshogaku Zasshi 1995; 69: 413-419.
32. Drobniewski F A, Caws M, Gibson A, Young D. Modern laboratory diagnosis of tuberculosis. Lancet Infect Dis 2003; 3: 141-147.
33. Cohen T, Sommers B, Murray M. The effect of drug resistance on the fitness of Mycobacterium tuberculosis. Lancet Infect Dis 2003; 3: 13-21.